Our vision

Moving diagnostic frontiers in dermatology.

Our mission

We build leading innovative molecular diagnostic solutions at scale and at point of need for diagnostic laboratories, dermatologists and academic and pharmaceutical research organizations. With our quick, precise and automated tests, we enable skin experts to recommend the best treatments for human skin health.

Company history

Dermagnostix was founded as a spin-off from the Hahn-Schickard Institut in Freiburg, the Helmholtz Zentrum München (HMGU) and TU Munich, after decades of top-level research in dermatology, immunology, bioinformatics and microfluidics. We are located in Southern Germany (Freiburg).

Game-changing modern therapies have evolved the treatment of inflammatory disease and skin cancer. Diagnostics have not kept pace with these therapeutic advances. Dermagnostix closes this gap bringing objective molecular results directly to the physician.

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Always unblock YouTube

Management

Prof. Natalie Garzorz-Stark, MD, PhD, MHBA

CEO, Co-Founder, Managing Director

Ludwig Gutzweiler

CTO, Managing Director

Martin Meyer

Head of QM & RA

Dermagnostix, a spin-off company of

Awards

2024

2022

2021

2020

2019

2018

Certificate

Since November 2022 Dermagnostix is officially EN ISO 13485 certified.

View certificate

Support programme INVEST

Dermagnostix was granted a notice of eligibility by BAFA as part of the INVEST funding measure of the Federal Ministry of Economics and Climate Protection to subsidize venture capital from private investors for young innovative companies.

Learn more